Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).

"Today we were also happy to announce the appointment of Paul Sekhri to serve as our new Chairman of the Board, effective October 2, 2017. We are delighted to have Paul join us and are confident that we will benefit from his leadership and expertise during the next exciting chapter of our corporate growth," Dr. Cohen-Dayag concluded.

For earnings history and earnings-related data on Compugen (CGEN) click here.